Daniel Barber

President and CEO

Daniel Barber (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Aquestive Therapeutics, Inc. (AQST). The largest single filing was $753K of AQST (180,677 sh × $4.17, as filed), executed Mar 10.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.1M

shares × price, as filed

Last traded

Sep 15

Filed Sep 16

Median ADV $10.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

AQST Aquestive Therapeutics, Inc. AQST · 0 buys · 5 sells 5 filings

Recent filings

AQSTSALE Aquestive Therapeutics, Inc. View filing → $120K
25,000 sh × $4.82
Exec Sep 15
Filed Sep 16 · 2:00 PM ET AQSTSALE Aquestive Therapeutics, Inc. View filing → $107K
25,000 sh × $4.29
Exec Aug 17
Filed Aug 18 · 4:13 PM ET AQSTSALE Aquestive Therapeutics, Inc. View filing → $104K
25,000 sh × $4.16
Exec Jun 15
Filed Jun 16 · 5:30 PM ET AQSTSALE Aquestive Therapeutics, Inc. View filing → $753K
180,677 sh × $4.17
Exec Mar 10
Filed Mar 11 · 5:30 PM ET AQSTSALE Aquestive Therapeutics, Inc. View filing → $551K
91,343 sh × $6.03
Exec Sep 26 2025
Filed Sep 29 2025 · 5:30 PM ET